A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination … CR Boland, SN Thibodeau, SR Hamilton, D Sidransky, JR Eshleman, ... Cancer research 58 (22), 5248-5257, 1998 | 5100 | 1998 |
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability A Umar, CR Boland, JP Terdiman, S Syngal, A Chapelle, J Rüschoff, ... Journal of the National Cancer Institute 96 (4), 261-268, 2004 | 3803 | 2004 |
A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines MA Rodriguez-Bigas, CR Boland, SR Hamilton, DE Henson, S Srivastava, ... Journal of the National Cancer Institute 89 (23), 1758-1762, 1997 | 1422 | 1997 |
α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ... Gastroenterology 137 (1), 110-118, 2009 | 857 | 2009 |
Molecular damage in the bronchial epithelium of current and former smokers II Wistuba, AK Virmani, AF Gazdar, S Lam, J LeRiche, C Behrens, ... Journal of the National Cancer Institute 89 (18), 1366-1373, 1997 | 623 | 1997 |
Trends in biomarker research for cancer detection PR Srinivas, BS Kramer, S Srivastava The lancet oncology 2 (11), 698-704, 2001 | 573 | 2001 |
Addressing overdiagnosis and overtreatment in cancer: a prescription for change LJ Esserman, IM Thompson, B Reid, P Nelson, DF Ransohoff, HG Welch, ... The lancet oncology 15 (6), e234-e242, 2014 | 572 | 2014 |
The human proteome project: current state and future direction P Legrain, R Aebersold, A Archakov, A Bairoch, K Bala, L Beretta, ... Molecular & cellular proteomics 10 (7), 2011 | 467 | 2011 |
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of … OJ Semmes, Z Feng, BL Adam, LL Banez, WL Bigbee, D Campos, ... Clinical chemistry 51 (1), 102-112, 2005 | 439 | 2005 |
Proteomics for cancer biomarker discovery PR Srinivas, M Verma, Y Zhao, S Srivastava Clinical chemistry 48 (8), 1160-1169, 2002 | 413 | 2002 |
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 384 | 2020 |
Proteomics in early detection of cancer PR Srinivas, S Srivastava, S Hanash, GL Wright Jr Clinical chemistry 47 (10), 1901-1911, 2001 | 384 | 2001 |
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens DW Cramer, RC Bast Jr, CD Berg, EP Diamandis, AK Godwin, P Hartge, ... Cancer prevention research 4 (3), 365-374, 2011 | 374 | 2011 |
A compendium of potential biomarkers of pancreatic cancer HC Harsha, K Kandasamy, P Ranganathan, S Rani, S Ramabadran, ... PLoS medicine 6 (4), e1000046, 2009 | 357 | 2009 |
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation C Sun, A Dobi, A Mohamed, H Li, RL Thangapazham, B Furusato, ... Oncogene 27 (40), 5348-5353, 2008 | 327 | 2008 |
Early detection of sporadic pancreatic cancer: summative review ST Chari, K Kelly, MA Hollingsworth, SP Thayer, DA Ahlquist, ... Pancreas 44 (5), 693-712, 2015 | 311 | 2015 |
Can urinary PCA3 supplement PSA in the early detection of prostate cancer? JT Wei, Z Feng, AW Partin, E Brown, I Thompson, L Sokoll, DW Chan, ... Journal of Clinical Oncology 32 (36), 4066, 2014 | 310 | 2014 |
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas K Yashima, LA Litzky, L Kaiser, T Rogers, S Lam, II Wistuba, S Milchgrub, ... Cancer research 57 (12), 2373-2377, 1997 | 304 | 1997 |
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification B Furusato, SH Tan, D Young, A Dobi, C Sun, AA Mohamed, ... Prostate cancer and prostatic diseases 13 (3), 228-237, 2010 | 277 | 2010 |
Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics KE Krueger, S Srivastava Molecular & Cellular Proteomics 5 (10), 1799-1810, 2006 | 269 | 2006 |